Results

Total Results: 2,228 records

Showing results for "disease".

401. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
     January 01, 2010 - Burden of Diabetes and Its Classification Diabetes mellitus is defined as a group of metabolic diseases … , cerebrovascular disease, and peripheral arterial disease). 1 The prevalence of diagnosed diabetes … Cerebrovascular disease Peripheral arterial disease Severe hypoglycemia Quality of life … peripheral arterial disease) c. …  Cerebrovascular disease  Peripheral arterial disease Severe hypoglycemia Quality of life

402. Thompson_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/thompson_eccs2012.pdf
     January 01, 2012 - o Combination of disease comprehension o Awareness of health behavior and treatment guidelines/options … Information (1 of 2) • Evidential  approaches present  the evidence  of the effects of the disease …  If disease  and death  were  viewed  as  inevitable,  participants   speculated   … o Anecdotes can influence a person’s belief about how behavior, disease, and treatment affects him … o Anecdotes allow people to identify the recipients of treatment and those experiencing  disease to

403. Update Topic CER 31 Clostridium difficile NSD FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/c-diff-infections-nomination-140925.pdf
     February 19, 2014 - (a) Does effectiveness vary by disease severity or strain? … § Vancomycin versus metronidazole § Severe disease, vancomycin versus metronidazole § Fidaxomicin … § Does effectiveness vary by disease severity or strain?

404. Gout Executive-2016 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive-2016.pdf
     January 01, 2016 - hypertriglyceridemia, hypercholesterolemia, type 2 diabetes, metabolic syndrome, chronic kidney disease … condition (especially patients in the early stages of the disease) for the purpose of enrollment in … studies of disease management.17 Therefore, a question of importance is whether any combination … Thus, they may be in an early stage of the disease, or at least will be less advanced in the disease … Performance of classification criteria for gout in early and established disease.

405. Crosscutting Hi Impact (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting_hi_impact.pdf
     January 01, 2012 - material on interventions in this Executive Summary and report is organized according alphabetically by disease … exists for technologies that might help improve patient adherence with medication dosages for chronic disease … specificity and sensitivity, would actually translate to improved patient-centered outcomes, such as disease … [With this intervention,] better disease state management could occur.” 12 However, two other experts … model to address the problem of hepatitis C virus (HCV) infection in New Mexico and have used that disease

406. Technical Brief 13: Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
     December 01, 2012 - will develop recurrence or die from their disease. … generally measured by disease-free survival. … Clinical Validity (Diagnostic Accuracy) How is recurrence defined, e.g. local disease, distant disease … o For disease-free survival, how was it determined? … Diseases of the Colon & Rectum. 2005 Dec;48(12):2238-48. PMID: 16228831. 4.

407. Methods Guide for Medical Test Reviews Chapter 9 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-performance_methods.pdf
     July 01, 2012 - This can be applicable to diseases that are defined in complex ways or qualitatively (e.g., based both … Such an example could be a complex disease such as psoriatic arthritis. … There is no single symptom, sign, or measurement that suffices to make the diagnosis of the disease … Most studies and some guidelines define AHI ≥15 events per hour of sleep as suggestive of the disease … Estimating disease prevalence in the absence of a gold standard.

408. Clopidogrel after Drug-Eluting Stent Implantation: Is current practice sufficient (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
     March 01, 2009 - Exclusion criteria included congenital heart disease, moderate/severe valvular heart disease, prior … All study information was stored in the Duke Databank for Cardiovascular Disease (DDCD). … , third heart sound, history of cerebrovascular disease, history of peripheral vascular disease), diagnostic … catheterization findings (left ventricular ejection fraction, extent of coronary artery disease), … disease, renal disease, liver disease, metastatic cancer, solid tumor), stent characteristics (average

409. Measuring-Blood-Pressure Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_executive.pdf
     January 01, 2012 - highlighting the contribution of hypertension directly and indirectly to the development of numerous diseases … modifiable risk factor for coronary artery disease, stroke, peripheral vascular disease, congestive … events, terminal illnesses, or advanced kidney disease. … , diabetes mellitus, and chronic kidney disease. … End-stage renal disease alone was not significantly different.

410. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
     September 01, 2011 - amount and quality of the information available regarding treatment of JIA compared to other chronic diseases … Reviewer #2 Introduction (Pg 19, line 54) RF-poly and RF+poly - these really are two different diseases … The sub-types of JIA/JRA/JCA are all quite different diseases in terms of presentation, response, outcome … Juvenile idiopathic arthritis is not a disease. … The potential role of disease registries has been added.

411. Masks for Prevention of COVID-19 in Community and Healthcare Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-masks-prevention-covid-version-1.pdf
     December 01, 2021 - disease caused by MERS-CoV infection). … disease caused by MERS-CoV infection) … Centers for Disease Control. … Centers for Disease Control. … https://www.who.int/emergencies/diseases/n ovel-coronavirus-2019/global-research-on- novel-coronavirus

412. CER 222: Evidence Summary: Achieving Health Equity in Preventive Services (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-evidence-summary-health-equity.pdf
     January 01, 2020 - summarize research on achieving health equity in 10 preventive services for cancer, cardiovascular disease … National Cancer Institute (NCI), and the National Institute of Diabetes and Digestive and Kidney Diseases … addresses five KQs on achieving health equity in preventive services related to three high-burden diseases … in the United States: cancer, cardiovascular disease, and diabetes. … bAlso relevant to cardiovascular disease prevention.

413. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_executive.pdf
     October 01, 2011 - subclinical thyroid dysfunction might lead to a decrease in the morbidity associated with overt thyroid disease … , heart disease, and possibly osteoporosis. … Currently, it is unclear whether screening and early treatment for thyroid disease is better than not … Screening for Thyroid Disease. Systematic Evidence Review No. 23. … Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.

414. Appendix A: Literature Search (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/postpartum-care-protocol-appendix%20A.pdf
     December 09, 2021 - transitional care" OR "comanagement" OR "co-management" OR "case management" OR "interdisciplinary care" OR "disease … Continuity of Patient Care"[MeSH] OR "Patient-Centered Care"[MeSH] OR "Patient Care Planning"[MeSH] OR "Disease … transitional care" OR comanagement OR co- management OR "case management" OR "interdisciplinary care" OR "disease … transitional care" OR comanagement OR co-management OR "case management" OR "interdisciplinary care" OR "disease … Continuity of Patient Care"+) OR (MH "Patient-Centered Care"+) OR (MH "Patient Care Planning"+) OR (MH "Disease

415. Methods Guide for Medical Test Reviews Chapter 11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-genetic_methods.pdf
     July 01, 2012 - We have chosen to use a broad definition in agreement with that of the Centers for Disease Control and … Some examples include heart disease and diabetes. … be difficult to assess their risk of developing the disease. … drift, and inbreeding.36 In addition, when numerous polymorphisms are tested for associations with diseases … Many genetic variants identified that are thought to influence susceptibility to diseases are associated

416. Therapies for Clinically Localized Prostate Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_clinician.pdf
     January 01, 2016 - are diagnosed with prostate cancer have cancer confined to the prostate gland (clinically localized disease … Men with slowly progressing disease who are more likely to die of other causes could be spared unnecessary … determine which subgroups of patients might benefit most from these therapies based on patient and disease … prostate cancer, a key limitation in accruing high- quality data is the long natural history of the disease … the last 10 to 15 years, patients in the reviewed studies were likely older and had more advanced disease

417. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-genetic.ppt
     June 01, 2012 - Centers for Disease Control and Prevention. Public Health Genomics. Genomic Testing. … Centers for Disease Control and Prevention. Public Health Genomics. Genomic Testing. … Is it used to determine the future risk of disease in asymptomatic individuals? … In addition, when numerous polymorphisms are tested for associations with diseases or outcomes, as in … Many genetic variants identified that are thought to influence susceptibility to diseases are eventually

418. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-genetic.ppt
     June 01, 2012 - Centers for Disease Control and Prevention. Public Health Genomics. Genomic Testing. … Centers for Disease Control and Prevention. Public Health Genomics. Genomic Testing. … Is it used to determine the future risk of disease in asymptomatic individuals? … In addition, when numerous polymorphisms are tested for associations with diseases or outcomes, as in … Many genetic variants identified that are thought to influence susceptibility to diseases are eventually

419. high-cholesterol-medicines-update-protocol-130516 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
     December 31, 2013 - cause of disability.1 Atherosclerosis plays a major role in the development of certain cardiovascular diseases—coronary … These atherosclerotic diseases affect 15.4 million Americans.1 Elevated blood lipids are a major risk … ; CKD = chronic kidney disease; CVD = cardiovascular disease; DPP-4 = dipeptidyl peptidase IV; ER = … mellitus, patients with pre-existing CVD including those with established vascular or cerebrovascular diseases … and without  preexisting cardiovascular disease.

420. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0398_06-17-2008.pdf
     January 01, 2008 - resistance, malnutrition-inflammation complex syndrome, or other co-morbid conditions such as liver disease … other measures of iron metabolic status to assess iron deficiency in patients with chronic kidney disease … )  Anemia in patients with end-stage renal disease (ESRD) is a risk factor for increased mortality